{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:06:05Z","timestamp":1790186765426,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Science of The Total Environment"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.scitotenv.2023.168040","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T01:39:02Z","timestamp":1698025142000},"page":"168040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Further contribution to the discussion on perfluorohexyloctane eye drops in dry eye disease"],"prefix":"10.1016","volume":"906","author":[{"given":"Verena","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kr\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Burian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Grillenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Korward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Roesky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scitotenv.2023.168040_bb0005","series-title":"Dry Eye Syndrome Preferred Practice Pattern","author":"American Academy of Ophthalmology","year":"2018"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0010","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jtos.2013.07.003","article-title":"Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting","volume":"11","author":"Baudouin","year":"2013","journal-title":"Ocul Surf."},{"key":"10.1016\/j.scitotenv.2023.168040_bb0015","first-page":"6","article-title":"Ecotoxicity of disinfectant benzalkonium chloride and its mixture with antineoplastic drug 5-fluorouracil towards alga Pseudokirchneriella subcapitata","volume":"18","author":"Elersek","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0020","series-title":"Environmental Assessment of Human Drug and Biologics Applications","author":"FDA Guidance for Industry","year":"1998"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0025","series-title":"Developing Drugs for Treatment, Draft Guidance, December","author":"FDA Guidance for Industry Dry Eye","year":"2020"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0030","unstructured":"Gu\u00edas espa\u00f1olas de la enfermedad de ojo seco, 2018."},{"key":"10.1016\/j.scitotenv.2023.168040_bb0035","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1021\/acs.estlett.0c00437","article-title":"Increased use of quaternary ammonium compounds during the SARS-CoV-2 pandemic and beyond: consideration of environmental implications","volume":"7","author":"Hora","year":"2020","journal-title":"Environ. Sci. Technol. Lett."},{"issue":"3","key":"10.1016\/j.scitotenv.2023.168040_bb0045","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf."},{"key":"10.1016\/j.scitotenv.2023.168040_bb0050","series-title":"Poster presented at: Association for Research in Vision and Ophthalmology 2018 Annual Meeting","article-title":"Ocular and systemic distribution of 14C-perfluorohexyloctane following topical ocular administration to rabbits","author":"Kr\u00f6sser","year":"2018"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0055","unstructured":"Leitlinie von BVA und DOG Trockenes Auge. 2019."},{"key":"10.1016\/j.scitotenv.2023.168040_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jhazmat.2022.130393","article-title":"Quaternary ammonium compounds of emerging concern: classification, occurrence, fate, toxicity and antimicrobial resistance","volume":"445","author":"Mohapatra","year":"2023","journal-title":"J. Hazard. Mater."},{"issue":"3","key":"10.1016\/j.scitotenv.2023.168040_bb0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s40123-023-00669-1","article-title":"Dry eye disease associated with meibomian gland dysfunction: focus on tear film characteristics and the therapeutic landscape","volume":"12","author":"Sheppard","year":"2023","journal-title":"Ophthalmol Therapy"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajo.2023.03.008","article-title":"NOV03 for signs and symptoms of dry eye disease associated with meibomian gland dysfunction: the randomized phase 3 MOJAVE study","volume":"252","author":"Sheppard","year":"2023","journal-title":"Am J. Ophthalmol."},{"issue":"9","key":"10.1016\/j.scitotenv.2023.168040_bb0075","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/ICO.0000000000002622","article-title":"A randomized clinical study (SEECASE) to assess efficacy, safety, and tolerability of NOV03 for treatment of dry eye disease","volume":"40","author":"Tauber","year":"2021","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.scitotenv.2023.168040_bb0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ophtha.2022.12.021","article-title":"NOV03 for dry eye disease associated with meibomian gland dysfunction: results of the randomized phase 3 GOBI study","volume":"130","author":"Tauber","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.scitotenv.2023.168040_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamaophthalmol.2023.0270","article-title":"Perfluorohexyloctane eye drops for dry eye disease associated with meibomian gland dysfunction in Chinese patients: a randomized clinical trial","volume":"141","author":"Tian","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"2022","key":"10.1016\/j.scitotenv.2023.168040_bb0090","article-title":"Systematic developmental toxicity assessment of a structurally diverse library of PFAS in zebrafish","volume":"431","author":"Truong","year":"2022","journal-title":"J. Hazard. Mater."},{"key":"10.1016\/j.scitotenv.2023.168040_bb0095","series-title":"United Nations (UN) ST\/SG\/AC10\/30\/Rev.4. New York, Geneva: United Nations; 2011. Globally Harmonized System of Classification and Labelling of Chemicals","author":"UN","year":"2011"},{"key":"10.1016\/j.scitotenv.2023.168040_bb0100","author":"US Environmental Protection Agency"}],"container-title":["Science of The Total Environment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0048969723066676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0048969723066676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:30:01Z","timestamp":1790184601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0048969723066676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":19,"alternative-id":["S0048969723066676"],"URL":"https:\/\/doi.org\/10.1016\/j.scitotenv.2023.168040","relation":{},"ISSN":["0048-9697"],"issn-type":[{"value":"0048-9697","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Further contribution to the discussion on perfluorohexyloctane eye drops in dry eye disease","name":"articletitle","label":"Article Title"},{"value":"Science of The Total Environment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scitotenv.2023.168040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"168040"}}